ONGC Q3FY22 preview: Street expects 15% revenue growth

State-owned Oil and Natural Gas Corporation (ONGC) will report its Q3 earnings on Friday and the street expects it to be a good quarter that will be led by higher crude oil prices. Expect revenues to grow on a quarter-on-quarter basis by around 15 percent.

Expect EBITDA growth of 19 percent, margins are expected go up by 200 basis points and profits will see a decline of 3.50 percent. Now higher EBITDA this time around will be led by an 18 percent sequential increase in realisation at $75 a barrel, higher price of value-added products, and also higher realisation in gas prices.

The stock has done really well in the last one year and is up 70 percent and it still trades at around 5.6 times FY23 EPS.

Watch the accompanying video of CNBC-TV18’s Sonal Bhutra for more details.

Catch all the stock market live updates here.

Mahindra & Mahindra Q3 preview: Street expects revenue up by 8.50%

Mahindra & Mahindra (M&M) will report its Q3 earnings on Thursday and street expects a mixed bag. Overall the numbers will look sluggish because the tractor demand has been under pressure on account of unseasonal rains, as well as the cost inflation has hit margins this time around.

The passenger vehicle segment, the SUV segment have grown well, there are price hikes that the company has taken there. So that will offset the slowdown that the company is seeing in the tractor segment.

Overall expect revenues to go up by 8.50 percent, the EBITDA will fall by 22 percent as there is cost inflation which has hit the margins. So the overall margins will fall to 12 percent versus 17 percent same time last year, and the profits are also expected to fall by about 21 percent odd.

Watch the accompanying video of CNBC-TV18’s Sonia Shenoy for more details.

SAIL Q3 preview: Street expects topline growth of 35%

Steel Authority of India (SAIL) will report its Q3 earnings on Wednesday and the street expects numbers not to be too great. CNBC-TV18 poll expects topline growth close to around 35 percent, EBITA to come down by around 17 percent.

Margins should come down to around 15.8 percent and that will be sharply lower both on a year-on-year basis as well as on a sequential basis. Net profit, CNBC-TV18 poll expects a jump of close to around 50 percent.

Watch the accompanying video of CNBC-TV18’s Nigel D’Souza for more details.

Catch all stock market updates here

JSW Steel Q3 preview: Street expects topline growth of 60%

JSW Steel will report its Q3 earnings on Friday. CNBC-TV18 poll expects topline growth of close to around 60 percent and operating profit that is the EBITDA should come up close to around 60 percent.

On a year-on-year basis, margins will be more or less at around 27-27.50 percent odd, though on a sequential basis there will be a sharp decline.

The revenue growth is going to be led by a few factors as on a year-on-year basis steel prices are up big time. The consolidation of Bhushan Power and Steel assets will add to volumes and will add to revenues as well.

Watch the accompanying video of CNBC-TV18’s Nigel D’Souza for more details.

HUL Q3 preview: Street expects volume growth of around 1-2%

Hindustan Unilever

Hindustan Unilever (HUL) will be reporting its Q3 results on Thursday. The stock is almost 15 percent away from its record high, and it is trading at around 53-54 times.

CNBC-TV18 poll is expecting flat volume growth just around 1 to 2 percent underlying volume growth. HUL has taken a fair amount of price hikes owing to the input costs inflation, so a 7 to 8 percent price hike and management commentary on rural demand, as well as inflation would be extremely crucial to watch out for.

Watch the accompanying video of CNBC-TV18’s Mangalam Maloo for more details.

Expect weak 3rd quarter for auto sector, says Elara Capital

In our special segment, ‘Quarter Se Quarter Tak’, Jay Kale, Senior Vice President Research at Elara Capital, discusses the expectations from the auto sector in the third quarter.

Kale said, “We are expected to see quite a weak Q3, of course, marred by semiconductor shortage at the passenger vehicle and very weak festive season for the two-wheelers. Commercial Vehicles were the only positive because of a better mining and construction activity.”

He added, “I think a large part of the commodity pressures will be kind of seen in Q3 and that could be one of the last quarter before we see a recovery from Q4 levels. If we see a pickup in demand in Q4, which was expected a few days back until the third wave kind of hit. We are expecting that passenger vehicles should meaningfully improve in the fourth quarter and then in FY23. Two-wheelers will take a bit of time.”

For full interview, watch accompanying video…

Also Read: Auto Q3 earnings preview: Street expects weakness due to chip shortage, higher raw material prices

 5 Minutes Read

Auto Q3 earnings preview: Street expects weakness due to chip shortage, higher raw material prices

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

It is going to be a weak quarter for the auto sector this time around because of multiple reasons. One, there has been a global semiconductor shortage that has hit production of OEMs, two – the demand has been quite weak, especially in the festive season, and especially in mass market segments like two-wheelers and the entry level car segment.

It is going to be a weak quarter for the auto sector this time around because of multiple reasons. One, there has been a global semiconductor shortage that has hit production of OEMs, two – the demand has been quite weak, especially in the festive season, and especially in mass market segments like two-wheelers and the entry level car segment.

Also higher raw material prices have hit margins and continue to do so and there has been a very tepid recovery in the rural markets.

Watch the accompanying video of CNBC-TV18’s Sonia Shenoy for more details.

Also Read: Expect weak 3rd quarter for auto sector, says Elara Capital

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

 5 Minutes Read

Pharma Q3 preview: Street expects 4-6% revenue growth

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

 Listen to the Article (6 Minutes)

Summary

Q3FY22 is expected to be a largely normalised quarter for pharmaceutical companies as COVID-19 cases have started to subside. Street is expecting around 4 to 6 percent revenue growth.

Q3FY22 is expected to be a largely normalised quarter for pharmaceutical companies as COVID cases start to subside. Street is expecting around 4 to 6 percent revenue growth. So, overall a modest quarter.

Domestic formulations are expected to see high single-digit to double-digit growth led by a recovery in the acute segment, which is the cough and cold segment etc.

US markets are likely to be subdued led by a lack of high-value launches as well as price pressure in the past couple of quarters.

Factors to watch out for will be margin, because of the impact of US price pressure as well as higher input costs.

Commentary for pharmaceutical companies continues to be key – for example, COVID-19 drug and vaccine opportunities for the likes of Cadila’s ZyCoV-D, DRL’s Sputnik, Biocon’s tie-up with Serum, Divis Labs, and Molnupiravir.

US FDA inspections or any progress in terms of outstanding issues for companies will be watched, for example, Lupin, Biocon, Cipla, Cadila, Sun Pharma, and Aurobindo Pharma.

New approval launches in the US will also be watched in terms of commentary.

Coming to stock-specific developments,  US speciality business will aid Sun Pharma’s overall business. Dr Reddy’s  US growth momentum will also be watched; Cipla gains in key drugs such as inhaler Albuterol in the US will be key, Lupin’s Spiriva generic launch in the US, which is also an inhaler as well as their diagnostic business ramp-up and Aurobindo’s injectable business de-merger, commentary on these will be top of mind.

Catch all stock market updates here

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

 Daily Newsletter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Previous Article

Oil Fluctuates as Traders Assess China’s Vow, Unrest in Libya

Next Article

Shanghai residents turn to NFTs to record COVID lockdown, combat censorship

LIVE TV

today's market

index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -72.15
sensex ₹1,882.60 +28.30
nifty IT ₹2,206.80 +30.85
nifty bank ₹1,318.95 -14.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95
index Price Change
nifty 50 ₹16,986.00 -7.15
sensex ₹1,882.60 +8.30
nifty IT ₹2,206.80 +3.85
nifty bank ₹1,318.95 -1.95

Currency

Company Price Chng %Chng
Dollar-Rupee 73.3500 0.0000 0.00
Euro-Rupee 89.0980 0.0100 0.01
Pound-Rupee 103.6360 -0.0750 -0.07
Rupee-100 Yen 0.6734 -0.0003 -0.05
Quiz
Powered by
Are you a Crypto Head? It’s time to prove it!
10 Questions · 5 Minutes
Start Quiz Now
Win WRX (WazirX token) worth Rs. 1500.
Question 1 of 5

What coins do you think will be valuable over next 3 years?

Answer Anonymously

Should Elon Musk be able to buy Twitter?

Sanford Bernstein: Expect price erosion to heighten on YoY basis

In our special segment, ‘Quarter Se Quarter Tak’, Nithya Balasubramanian, Director of Sanford Bernstein discusses the expectations from the pharma sector in the third quarter.

Balasubramanian said, “I am expecting price erosion to be heightened on a year-on-year basis this quarter as well. If you go back to the biggest reason why we are seeing this heightened deflation is actually because of higher inventory levels in the channel and if you look at the large retailers’ inventory levels, it does seem at least last quarter, it seems still slightly above pre-COVID levels. This means this quarter again as the inventory is normalising we are likely to see sustained deflation.”

She added, “I am hopeful that starting 2022 this trend should reverse because inventory levels should have normalised and I am not seeing anything structurally that is likely to keep deflation at a higher number. So I am hoping on a year-on-year basis 2022 will look much better than 2021.”

For full interview, watch accompanying video…

Also Read: Pharma Q3 preview: Street expects 4-6% revenue growth

Bajaj Finance Q3 earnings preview: Street expects robust growth in profitability

Bajaj Finance will be reporting Q3 results and a strong quarter is expected in terms of profitability due to a decline in provisions as per analyst estimates.

According to its business update, AUM growth on a year-on-year basis is at the north of 26 percent and is the best in last seven quarters and sequentially, the loan growth has been 8.6 percent which is the best in last eight quarters.

They have already mentioned that there is no adverse impact on NPAs from RBI’s recent ruling or of the new method under collections. So new loans continued to trend upwards 17.50 percent sequential growth despite a strong base of 36.7 percent quarter-on-quarter growth that it saw in the previous quarter.

Watch the accompanying video of CNBC-TV18’s Abhishek Kothari for more details.